Catalog No.
YVV13001
Expression system
E. coli
Species
Monkeypox virus (strain Zaire-96-I-16) (MPX)
Protein length
Leu428-Thr695
Predicted molecular weight
34.09 kDa
Nature
Recombinant
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
NP_536564.1
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02%SKL, 1mM EDTA, 5% Trehalose, 2% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
A27L
Note
For research use only.
Epitope detection in the envelope of intracellular naked orthopox viruses and identification of encoding genes., PMID:7513922
Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates., PMID:12620810
Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox., PMID:15078924
Subunit recombinant vaccine protects against monkeypox., PMID:16888017
Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates., PMID:19833247
Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain., PMID:24050999
Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity., PMID:27637905
Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022., PMID:35906185
Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study., PMID:37475115
Immunoinformatic Approach for Rational Identification of Immunogenic Peptides Against Host Entry and/or Exit Mpox Proteins and Potential Multiepitope Vaccine Construction., PMID:37804521
Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques., PMID:38536937
Levels of antibodies against the monkeypox virus compared by HIV status and historical smallpox vaccinations: a serological study., PMID:38767199
The Generation and Characterization of Monoclonal Antibodies against the MPXV A29L Protein., PMID:39205158
Monkeypox virus A29L protein as the target for specific diagnosis and serological analysis., PMID:39570405
For research use only. Not for human or drug use.
